Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Nuclear cGAS Suppresses L1 Retrotransposition via TRIM41-ORF
2026-06-16
This study uncovers a noncanonical nuclear role for cGAS in repressing LINE-1 (L1) retrotransposition by promoting TRIM41-mediated ubiquitination and degradation of ORF2p. These findings illuminate a critical posttranslational genome surveillance mechanism with implications for aging and cancer biology.
-
TCF25 Regulates Lysosomal Cell Fate During Glucose Starvatio
2026-06-16
Ren et al. (2025) reveal that TCF25 acts as a nutrient sensor, modulating metabolic adaptation and cell death by enhancing V-ATPase-dependent lysosomal acidification during glucose starvation. Their findings uncover TCF25-mediated ferritinophagy as a key determinant of lysosomal cell death and tissue injury, offering new targets for metabolic and ischemic disease intervention.
-
hiPSC-Derived Intestinal Organoids Advance CYP2C19 Substrate
2026-06-15
This study presents a streamlined protocol for generating human iPSC-derived intestinal organoids, enabling more physiologically relevant pharmacokinetic studies of oral drug metabolism. The model overcomes key limitations of animal and Caco-2 systems, supporting robust evaluation of CYP2C19 substrate metabolism.
-
Mubritinib (TAK 165): Redefining Complex I Inhibition in Can
2026-06-15
Explore how Mubritinib (TAK 165) advances cancer biology and HER2 signaling pathway inhibition, with a focus on mechanistic depth and assay optimization. This article uniquely bridges mitochondrial research and translational oncology.
-
Deferoxamine Mesylate: Iron Metabolism, Lysosomal Fate, and
2026-06-14
Explore how Deferoxamine mesylate (from APExBIO) bridges mechanistic insight into iron metabolism and lysosomal adaptation with actionable strategies for translational researchers. This article uniquely connects TCF25-driven nutrient sensing, iron chelation, and HIF-1α stabilization, offering a practical roadmap for experimental design and clinical translation.
-
VER 155008: Optimizing HSP 70 Inhibitor Workflows in Cancer
2026-06-13
VER 155008, a potent adenosine-derived HSP 70 inhibitor, enables precise control over apoptosis and cell proliferation assays in cancer research. This guide delivers actionable workflow enhancements, troubleshooting strategies, and bridges the latest proteomic insights to experimental practice.
-
Eicosapentaenoic Acid: Optimized EPA Omega-3 Fatty Acid Work
2026-06-12
Eicosapentaenoic Acid (EPA) stands apart as a benchmark EPA omega-3 fatty acid for cardiovascular and immunology labs, delivering robust, reproducible outcomes in membrane modulation and lipid-lowering studies. This article translates recent mechanistic and workflow advances into hands-on, troubleshooting-oriented guidance to maximize assay impact.
-
Applied Protocols with 5,6-Dichloro-1-β-D-ribofuranosylbenzi
2026-06-12
Harness the translational power of 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) to precisely modulate transcriptional elongation, enabling robust workflows from cell fate engineering to antiviral research. This guide distills experimental insights, reference breakthroughs, and practical troubleshooting for maximizing DRB’s impact in high-fidelity assays.
-
One-step TUNEL FITC Apoptosis Detection Kit: Precision in DN
2026-06-11
The One-step TUNEL FITC Apoptosis Detection Kit empowers researchers to detect apoptosis with high specificity in both cultured cells and tissue sections. Its streamlined protocol and robust FITC-labeled dUTP incorporation facilitate reproducible quantification across cancer, neurodevelopmental, and toxicology studies.
-
0.4% Trypan Blue Solution: Technical Guide for Cell Viabilit
2026-06-11
0.4% Trypan Blue Solution offers a direct method for distinguishing live from dead cells in suspension, addressing the need for rapid, reproducible cell viability measurement in research workflows. It is best suited for standard cell counting and cytotoxicity assays, but not for clinical diagnostics or multiparametric applications requiring higher sensitivity or multiplexing.
-
STAT2 Coiled-Coil Degron Drives Zika Virus Interferon Evasio
2026-06-10
Parisien et al. elucidate how Zika virus NS5 targets a degron within the STAT2 coiled-coil domain for proteasomal degradation, thereby disabling interferon signaling. These findings clarify a key mechanism of viral immune evasion and offer new leads for therapeutic intervention.
-
TSPAN18 Stabilizes STIM1 to Drive Prostate Cancer Bone Metas
2026-06-10
Zhou et al. (2023) reveal that TSPAN18 protects STIM1 from TRIM32-mediated ubiquitination, promoting store-operated calcium entry (SOCE) and accelerating bone metastasis in prostate cancer. This mechanistic insight identifies potential molecular targets within the calcium signaling pathway for therapeutic intervention.
-
EZ Cap™ EPO mRNA (ψUTP): Advancing mRNA Stability & Neurorep
2026-06-09
Discover how EZ Cap™ EPO mRNA (ψUTP) unlocks next-generation human erythropoietin mRNA research through superior stability, capping, and translational efficiency. This in-depth analysis reveals unique mechanistic insights and strategic assay guidance beyond existing resources.
-
MEG3 Modulation of TGF-β1/PI3K/AKT in NiO NP-Induced Lung Fi
2026-06-09
The reference study uncovers how downregulation of lncRNA MEG3 contributes to pulmonary fibrosis following nickel oxide nanoparticle (NiO NP) exposure, acting via enhanced TGF-β1 expression and PI3K/AKT pathway activation. Importantly, the work demonstrates that the ALK5 inhibitor SB 431542 can suppress this profibrotic signaling, providing a mechanistic link and potential intervention strategy.
-
FAISL lncRNA Blocks FAK Proteolysis to Drive TNBC Progressio
2026-06-08
The reference study identifies the long noncoding RNA FAISL as a direct regulator of FAK protein stability in triple negative breast cancer (TNBC). By inhibiting Calpain 2-mediated FAK proteolysis, FAISL promotes tumor adhesion, proliferation, and metastasis, highlighting a novel mechanism and potential therapeutic target in aggressive breast cancer.